Semaglutide Eligibility Across All Current Indications for US Adults
This cross-sectional study uses National Health and Nutrition Examination Survey data to examine the number of US adults eligible for semaglutide across all current indications.
Related Articles
Living Your Best Life While Taking Blood Thinners
More than 8 million people in the United States are currently taking a blood thinner (anticoagulant) medication.
Apply Now for the JAMA Health Forum Editorial Fellowship
The JAMA Health Forum Editorial Fellowship will present 3 fellows with the opportunity to receive hands-on training in the editorial processes and policies of a…
Sudden Hemodynamic Deterioration of a Patient With Progressive Jaw Pain
This case report describes a diagnosis of left ventricular anterior free-wall rupture in a patient given anticoagulant treatment for subacute myocardial infarction.
A Unique Case of Opioid-Induced Myoclonus
This case report describes a case of opioid-induced myoclonus.
Subconjunctival Mass 30 Years After Melanoma Resection
A 70-year-old male is referred for evaluation of a conjunctival mass in the right eye, which has grown slowly over 27 years. Examination reveals a…
Global Antimicrobial Susceptibility Patterns of Staphylococcus aureus in Atopic Dermatitis
This meta-analysis assesses the antimicrobial susceptibility of Staphylococcus aureus in individuals with atopic dermatitis and analyzes differences according to the income level of country of…
Mild Traumatic Brain Injury and Criminal Charges and Convictions in Mid and Late Adolescence
This cohort study examines population data for Denmark to determine any associations between childhood mild traumatic brain injury (occurring before age 10 years) and criminal…
GLP-1 Receptor Agonists and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
This cohort study aims to determine whether use of glucagon-like peptide 1 receptor agonists are associated with lower risk of developing cirrhosis and its complications,…
Prevention of Anal Cancer in High-Risk Individuals
This JAMA Insights examines the treatment and rising prevalence of anal cancer in the US in high-risk groups, including people with HIV and immunosuppression associated…
Bringing Imaging Biomarkers Into Clinical Reality in Psychiatry
This Special Communication discusses the merits and feasibility of imaging biomarkers in psychiatry, balancing scientific and practical considerations.
